MDT

96.83

-2.02%↓

A

139.62

-3.71%↓

VEEV

222.3

+1.47%↑

HQY

85.02

-2.1%↓

NEOG

9.24

-2.22%↓

MDT

96.83

-2.02%↓

A

139.62

-3.71%↓

VEEV

222.3

+1.47%↑

HQY

85.02

-2.1%↓

NEOG

9.24

-2.22%↓

MDT

96.83

-2.02%↓

A

139.62

-3.71%↓

VEEV

222.3

+1.47%↑

HQY

85.02

-2.1%↓

NEOG

9.24

-2.22%↓

MDT

96.83

-2.02%↓

A

139.62

-3.71%↓

VEEV

222.3

+1.47%↑

HQY

85.02

-2.1%↓

NEOG

9.24

-2.22%↓

MDT

96.83

-2.02%↓

A

139.62

-3.71%↓

VEEV

222.3

+1.47%↑

HQY

85.02

-2.1%↓

NEOG

9.24

-2.22%↓

Search

Integra LifeSciences Holdings Corp

Fechado

SetorSaúde

12.41 -1.74

Visão Geral

Variação de preço das ações

24h

Atual

Mín

12.31

Máximo

12.62

Indicadores-chave

By Trading Economics

Rendimento

479M

-5.4M

Vendas

-14M

402M

Margem de lucro

-1.344

Funcionários

4,396

EBITDA

526M

54M

Recomendações

By TipRanks

Recomendações

Vender

Previsão para 12 meses

-1.6% downside

Dividendos

By Dow Jones

Próximos Ganhos

24 de fev. de 2026

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

-231M

1B

Abertura anterior

14.15

Fecho anterior

12.41

Sentimento de Notícias

By Acuity

40%

60%

129 / 361 Ranking em Healthcare

Pontuação Técnica

By Trading Central

Confiança

Strong Bearish Evidence

Integra LifeSciences Holdings Corp Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

16 de jan. de 2026, 23:29 UTC

Ações em Alta

Stocks to Watch: Atossa Therapeutics, Union Pacific

16 de jan. de 2026, 22:48 UTC

Aquisições, Fusões, Aquisições de Empresas

Rail Regulator Sends $71.5 Billion Union Pacific-Norfolk Southern Deal Back for Redo -- 2nd Update

16 de jan. de 2026, 22:43 UTC

Aquisições, Fusões, Aquisições de Empresas

Union Pacific: Additional Information Requested to Be Provided to Surface Transportation Board

16 de jan. de 2026, 22:22 UTC

Aquisições, Fusões, Aquisições de Empresas

Rail Regulator Sends $71.5 Billion Union Pacific-Norfolk Southern Deal Back for Redo -- Update

16 de jan. de 2026, 21:50 UTC

Conversa de Mercado
Aquisições, Fusões, Aquisições de Empresas

Tech, Media & Telecom Roundup: Market Talk

16 de jan. de 2026, 21:50 UTC

Conversa de Mercado
Aquisições, Fusões, Aquisições de Empresas

Auto & Transport Roundup: Market Talk

16 de jan. de 2026, 21:50 UTC

Conversa de Mercado

Basic Materials Roundup: Market Talk

16 de jan. de 2026, 21:50 UTC

Conversa de Mercado

Health Care Roundup: Market Talk

16 de jan. de 2026, 21:48 UTC

Conversa de Mercado
Aquisições, Fusões, Aquisições de Empresas

Union Pacific, Norfolk Southern Market Share Ruled as Faulty -- Market Talk

16 de jan. de 2026, 21:41 UTC

Conversa de Mercado
Aquisições, Fusões, Aquisições de Empresas

Union Pacific, Norfolk Southern Deal Rejection Leaves Questions -- Market Talk

16 de jan. de 2026, 21:38 UTC

Aquisições, Fusões, Aquisições de Empresas

Rail Regulator Sends $71.5 Billion Union Pacific-Norfolk Southern Deal Back for Redo -- WSJ

16 de jan. de 2026, 21:30 UTC

Aquisições, Fusões, Aquisições de Empresas

STB: Union Pacific, Norfolk Southern Application Doesn't Include 'Projected Market Shares' as Required

16 de jan. de 2026, 21:30 UTC

Aquisições, Fusões, Aquisições de Empresas

STB: Union Pacific, Norfolk Southern Application Doesn't Include Certain Schedules, Documents Expressly Made Part of Merger Agreement

16 de jan. de 2026, 21:30 UTC

Aquisições, Fusões, Aquisições de Empresas

STB: Union Pacific, Norfolk Southern Application Doesn't Contain Certain Information Required by Regulations

16 de jan. de 2026, 21:30 UTC

Aquisições, Fusões, Aquisições de Empresas

STB: Application Rejected Without Prejudice to Union Pacific, Norfolk Southern Refiling Revised Application Remedying Deficiencies

16 de jan. de 2026, 21:30 UTC

Aquisições, Fusões, Aquisições de Empresas

Surface Transportation Board: Union Pacific, Norfolk Southern Major Merger Application Filed Dec. 19 Incomplete

16 de jan. de 2026, 20:44 UTC

Ganhos

5 Takeaways From This Season's Wealth Management Earnings -- Barrons.com

16 de jan. de 2026, 20:42 UTC

Conversa de Mercado

Oil Futures Post Fourth Straight Weekly Gain -- Market Talk

16 de jan. de 2026, 20:28 UTC

Conversa de Mercado

U.S. Natural Gas Slips Ahead of Long Weekend -- Market Talk

16 de jan. de 2026, 19:12 UTC

Conversa de Mercado
Aquisições, Fusões, Aquisições de Empresas

Netflix Could Comment on Structure of Warner Bid During 4Q Results -- Market Talk

16 de jan. de 2026, 18:53 UTC

Conversa de Mercado

Global Crude Supply Enough to Absorb Any Iran Disruption -- Market Talk

16 de jan. de 2026, 18:41 UTC

Conversa de Mercado

Netflix's Ad Business Seen as Primary Revenue Driver in 2026 -- Market Talk

16 de jan. de 2026, 18:31 UTC

Conversa de Mercado

U.S. Oil Rig Count Rises By 1 to 410 -- Market Talk

16 de jan. de 2026, 17:20 UTC

Conversa de Mercado

Financial Services Roundup: Market Talk

16 de jan. de 2026, 17:20 UTC

Conversa de Mercado

Basic Materials Roundup: Market Talk

16 de jan. de 2026, 17:20 UTC

Conversa de Mercado

Health Care Roundup: Market Talk

16 de jan. de 2026, 17:03 UTC

Conversa de Mercado

Global Equities Roundup: Market Talk

16 de jan. de 2026, 17:03 UTC

Conversa de Mercado

All Eyes on Guidance for European Big Pharma Earnings Season -- Market Talk

16 de jan. de 2026, 16:32 UTC

Conversa de Mercado
Aquisições, Fusões, Aquisições de Empresas

Sanofi Needs Dealmaking to Offset Pipeline Disappointments -- Market Talk

16 de jan. de 2026, 16:20 UTC

Conversa de Mercado

Global Equities Roundup: Market Talk

Comparação entre Pares

Variação de preço

Integra LifeSciences Holdings Corp Previsão

Preço-alvo

By TipRanks

-1.6% parte inferior

Previsão para 12 meses

Média 12.33 USD  -1.6%

Máximo 14 USD

Mínimo 10 USD

Com base em 6 analistas de Wall Street que oferecem metas de preço de 12 meses para Integra LifeSciences Holdings Corp - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Vender

6 ratings

0

Comprar

2

Manter

4

Vender

Pontuação Técnica

By Trading Central

12.75 / 16.41Suporte e Resistência

Curto Prazo

Strong Bearish Evidence

Médio Prazo

Strong Bearish Evidence

Longo Prazo

Weak Bearish Evidence

Sentimento

By Acuity

129 / 361 Ranking em Saúde

Sentimento de Notícias

Evidência de Tendência de Alta

Volatilidade

Abaixo da média

Volume de Notícias (RCV)

Abaixo da média

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre Integra LifeSciences Holdings Corp

Integra LifeSciences Holdings Corporation manufactures and sells surgical instruments, neurosurgical products, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment; and surgical headlamps and instrumentation, as well as after-market services. It also sells instrument patterns, and surgical and lighting products to hospitals and surgery centers, as well as dental, podiatry, and veterinary offices. In addition, the company provides regenerative technology products for the treatment of acute wounds; and surgical tissue repair products for hernia, tendon, peripheral nerve repair and protection. Further, it offers skin and wound repair, plastics and surgical reconstruction products, bone grafts, and nerve and tendon repair products. The company offers its products directly through various sales forces and other distribution channels to the hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers, and health care providers in the United States, Europe, Asia Pacific, and internationally. Integra LifeSciences Holdings Corporation was incorporated in 1989 and is headquartered in Princeton, New Jersey.
help-icon Live chat